| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57a2f0e54461e3c9470b5418ff6bf4ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e17fc32930fbdb1c404ba3977c55e88d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6284823c1bb183b2784df28cd0898e7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_386298b4523769af2f2d70d5c1ebcd77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_085acf08ce8cf607ff98e6851a4998ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf8ea1c59ab323c88eb3035b2e111ad6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02 |
| filingDate |
2009-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f85a19e775a9350554fc354d4df7e614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73104c75576a69f78436241b3f55472f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad16cda6cfb8f425828d6ada4670128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_283a7b981f3015f78acca7048820fb18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93729a6a84e32003a52c2b03b1c7f9c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d68b8c1c14301ad8df202ace1f65a269 |
| publicationDate |
2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011190220-A1 |
| titleOfInvention |
Use of Defensin Alpha 1 and/or Defensin Alpha 4, as a Marker for Predicting Treatment Response and/or a Relapse in a Patient Suffering form Chronic Myeloid Leukemia |
| abstract |
The present invention pertains to the use of defensin α1 and/or defensin α4, as a marker for predicting and following the response of a patient suffering from chronic myeloid leukaemia to a treatment with imatinib. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2530593-C1 |
| priorityDate |
2008-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |